EN CÁNCER DE CABEZA
Y CUELLO.
17:00 h.
de Cáncer de Cabeza y Cuello
Conjunta en Tumores de
Cabeza y Cuello
Jueves 2 diciembre a las 16:00 h (CET) reunión virtual con la participación de los autores del "I Consenso Iberoamericano de Cáncer de ...Cabeza y Cuello en Pacientes no candidados a Platino" con debate en directo.
Inscripción: https://ttccgrupo.com/reuniones-ttcc-grupo/
Ayudas Investigación en Cáncer AECC 2022 - Profesionales Clínicos ...https://seom.org/apoyo-a-la-investigacion/premios-becas-seom/otros-premios-becas/208946-ayudas-investigacion-en-cancer-aecc-2022-profesionales-clinicos a través de @_SEOM
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human,... open-label, multicentre, phase 1 dose-escalation and dose-expansion study
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study
The safety findings support the use of evorpacept in combination with pembrolizumab or trastuzumab for patients with ...
www.thelancet.com
📄 Ya puedes consultar el consenso SEFF-SEOM para el genotipado de DPYD en pacientes candidatos a tratamiento con fluoropirimidinas.
...▶️ https://bit.ly/3FBUMmc
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced ...Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
PURPOSE Definitive or postoperative chemoradiation (CRT) is curative for human papillomavirusâassociated (HPV+) oropharyn...
ascopubs.org
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, ...multicentre, non-inferiority trial
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
Most patients with cancer develop, while receiving chemotherapy, immunotherapy, or both for a solid tumour, an adequat...
www.thelancet.com
Jueves 2 diciembre a las 16:00 h (CET) reunión virtual con la participación de los autores del "I Consenso Iberoamericano de Cáncer de ...Cabeza y Cuello en Pacientes no candidados a Platino" con debate en directo.
Inscripción: https://ttccgrupo.com/reuniones-ttcc-grupo/
Ayudas Investigación en Cáncer AECC 2022 - Profesionales Clínicos ...https://seom.org/apoyo-a-la-investigacion/premios-becas-seom/otros-premios-becas/208946-ayudas-investigacion-en-cancer-aecc-2022-profesionales-clinicos a través de @_SEOM
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human,... open-label, multicentre, phase 1 dose-escalation and dose-expansion study
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study
The safety findings support the use of evorpacept in combination with pembrolizumab or trastuzumab for patients with ...
www.thelancet.com
📄 Ya puedes consultar el consenso SEFF-SEOM para el genotipado de DPYD en pacientes candidatos a tratamiento con fluoropirimidinas.
...▶️ https://bit.ly/3FBUMmc
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced ...Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
PURPOSE Definitive or postoperative chemoradiation (CRT) is curative for human papillomavirusâassociated (HPV+) oropharyn...
ascopubs.org
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, ...multicentre, non-inferiority trial
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
Most patients with cancer develop, while receiving chemotherapy, immunotherapy, or both for a solid tumour, an adequat...
www.thelancet.com
TTCC en cifras
Entidades Colaboradoras
WEB en renovación gracias a la colaboración de Bayer
